Dendrion Ventures

Activity from announced rounds

Activity in this selectionparable-c33bec5b
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$37M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Healthtech1

By country

United States1

Rounds

1 in this selection
ReEmerge, Inc.

ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.

$37MSeries A
Participant